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Abstract
Background: The identification of new methods of evaluating patients with osteoporotic fracture
should focus on their usefulness in clinical situations such that they are easily measured and
applicable to all patients. Thus, the purpose of this study was to examine the association between
iliocostal distance and vertebral and non-vertebral fractures in patients seen in a clinical setting.
Methods:  Patient data were obtained from the Canadian Database of Osteoporosis and
Osteopenia (CANDOO). A total of 549 patients including 508 women and 41 men participated in
this cross-sectional study. There were 142 women and 18 men with prevalent vertebral fractures,
and 185 women and 21 men with prevalent non-vertebral fractures.
Results: In women multivariable regression analysis showed that iliocostal distance was negatively
associated with the number of vertebral fractures (-0.18, CI: -0.27, -0.09; adjusted for bone mineral
density at the Ward's triangle, epilepsy, cerebrovascular disease, inflammatory bowel disease,
etidronate use, and calcium supplement use) and for the number of non-vertebral fractures (-0.09,
CI: -0.15, -0.03; adjusted for bone mineral density at the trochanter, cerebrovascular disease,
inflammatory bowel disease, and etidronate use). However, in men, multivariable regression
analysis did not demonstrate a significant association between iliocostal distance and the number
of vertebral and non-vertebral fractures.
Conclusions: The examination of iliocostal distance may be a useful clinical tool for assessment
of the possibility of vertebral fractures. The identification of high-risk patients is important to
effectively use the growing number of available osteoporosis therapies.
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Background
Osteoporosis is one of the most prevalent chronic health
conditions. This condition is characterized by low bone
mineral density and microarchitectural deterioration of
bone tissue leading to increased bone fragility and risk of
fracture [1]. It is estimated that approximately 40% of
white women and 13% of men 50 years and older will ex-
perience at least one clinically recognized hip, spine or
distal forearm fragility fracture in their lifetime [2]. These
fractures result in physical, psychological and emotional
disabilities, and increased pain that can negatively influ-
ence quality of life [3,4].
Osteoporosis can be identified early during the course of
the disease by diagnostic tests. Bone mineral density
measurements provide the single best method for predict-
ing fracture risk [5] but densitometers are occasionally not
available and since the pathogenesis of fragility fractures
is multifactorial, bone mass is not the only factor that de-
termines risk.
A number of factors have been found to be associated
with fragility fractures, they include advanced age, posi-
tive family history, height, existing fracture, propensity to
falls, and postural instability [5–7]. Unfortunately, our
understanding of risk factors is still inadequate and thus,
there is a need for further research. The identification of
new risk factors should focus on their usefulness in clini-
cal situations such that they are easily measured, applica-
ble to all patients, and contribute prognostic information
that is independent of bone mineral density. The size of
the gap between the costal margin and pelvic ridge (ilio-
costal distance) may be validated to be a surrogate meas-
ure for the presence of osteoporosis and/or vertebral
fragility fractures and thereby may be a risk factor for fu-
ture fracture. Hence, the purpose of this cross-sectional
study was to examine the association between iliocostal
distance and vertebral and non-vertebral fractures in
women and men who were seen in a clinical setting.
Methods
Study design
Patient data were obtained from the Canadian Database
of Osteoporosis and Osteopenia (CANDOO). CANDOO
consists of approximately 10000 patients and involves 8
sites across Canada (Calgary, Saskatoon, Winnipeg, Ham-
ilton, Toronto, Montreal [2 sites], and Quebec City). This
database is a prospective registry designed to compile a
comprehensive set of osteoporosis-related clinical infor-
mation [8]. All patients referred to us and seen during the
course of routine specialist care were enrolled in CAN-
DOO. Patients data are aggregated using anonymous pa-
tient identifiers into a centrally maintained, fully keyed
and encoded relational database. In particular, the CAN-
DOO contains electronically stored information regard-
ing basic patient demographics, fracture history,
gynecological history, past use of osteoporosis-related
drug treatment, drug side effects, past use of corticoster-
oids and other medications, dietary calcium intake, smok-
ing habits, type and quantity of physical activities, fall
history, past medical history and family history including
fractures, a self administered osteoporosis health related
quality of life instrument, basic laboratory results, and
bone density measurements. One database record, with
over 400 data fields per patient, is generated for each pa-
tient at each clinical visit.
For the current analysis, the database was searched for
women and men who had iliocostal distance measure-
ments, and who were seen at the Saskatoon site. The Sas-
katoon location was chosen because it was the only
CANDOO site that recorded iliocostal distance values.
Iliocostal distance measurements and the number of prev-
alent fractures
Iliocostal distance was defined as the number of cm be-
tween the costal margin and the pelvic ridge of a patient,
measured in the midaxillary line (figure 1). The measure-
ment was determined by one investigator (WPO) using
fingerbreadths (1 finger = 2 cm). All patients were stand-
ing during the measurement. Prevalent vertebral and non-
vertebral fractures were determined using the CANDOO
questionnaire ("Have you ever had any fractures?"). Ver-
tebral fractures may or may not have been confirmed by
x-ray. Non-vertebral fractures included the ankle, arm,
clavicle, elbow, foot, heel, hand, hip, knee, leg, nose, pel-
vis, rib, shoulder, sacrum, and wrist. Multivariable linear
regression analyses were conducted to determine the rela-
tionship between iliocostal distance and the number of
vertebral and non-vertebral fractures.
Potential confounding variables
Potential confounding variables collected from CANDOO
included age; height; weight; menopausal status; age at
menopause; lumbar spine, trochanter, femoral neck, and
Ward's triangle bone mineral density (measurements
were made by dual energy x-ray absorptiometry using Ho-
logic or Lunar densitometers); prevalent vertebral fracture
status (yes/no); and prevalent non-vertebral fracture sta-
tus (yes/no); smoking status (never, previously, previous-
ly with interruptions, currently, currently with
interruptions); family history of fracture (yes/no);
number of alcoholic beverages consumed per week (in-
cluding beer, wine and liquor); number of falls during the
last 12 months; dietary calcium intake per day (measured
as mg/d and estimated by a food frequency question-
naire); number of minutes spent exercising per week
(such as walking, stair climbing, jogging, swimming, bicy-
cling, dancing, skiing and others); current medication use
(etidronate, alendronate fluoride, raloxifene, hormone re-BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/22
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placement or corticosteroids); calcium supplement status
(yes/no); vitamin D supplement status (yes/no); and co-
morbid conditions (lung disease, liver disease, thyroid
disease, cancer, visual problems that are not corrected by
eyeglasses or contacts, osteoporosis, inflammatory bowel
disease, epilepsy, coronary disease, cerebrovascular dis-
ease, rheumatoid arthritis, diabetes, and kidney failure).
Statistical analysis
All multivariable regression analyses were conducted sep-
arately for women and men. We determined regression
coefficient estimates as well as 95% confidence intervals
(CI) of the estimates. All factors listed in the potential
confounding variable section were assessed separately for
their association with the number of fractures. Variables
with a p-value < 0.2 were included in the multivariable
analysis. Variables with a high degree of multicollinearity
were removed. Model selection was determined using a
stepwise procedure. If necessary, the iliocostal distance
variable was force into the final model. All statistical anal-
yses were performed on a Dell computer using the SAS/
STAT (version 8.1; SAS Institute Inc., Cary, NC, USA) soft-
ware package.
Results
A total of 549 patients including 508 women and 41 men
participated in this cross-sectional study. Table 1 shows
patients' characteristics at study entry for both women and
men. A total of 142 women and 18 men had prevalent
vertebral fractures, and 185 women and 21 men had prev-
alent non-vertebral fractures. The number of prevalent
vertebral and non-vertebral fractures varied from 0 to 9
and 0 to 7 in women and 0 to 8 and 0 to 6 in men, respec-
tively. Of the patients who sustained a vertebral fracture,
57 (40.1%), 34 (23.9%), 23 (16.2%) and 28 (19.7%)
women, and 11 (61.1%), 3 (16.7%), 2 (11.1%), and 2
(11.1%) men had 1, 2, 3, or 4+ vertebral fractures. A total
of 112 (60.5%), 48 (25.9%), 16 (8.6%), and 9 (4.9%)
women and 10 (47.6%), 7(33.3%), 1 (4.8%), and 3
(14.3%) men had had 1, 2, 3, or 4+ non-vertebral frac-
tures, respectively. The mean (SD) iliocostal distance for
women with a vertebral, non-vertebral and no fracture
was 3.49 (1.81) cm, 3.84 (1.69) cm and 4.53 (1.52) cm as
compared with 4.22 (1.52) cm, 4.67 (1.43) cm, and 4.77
(1.54) cm for men. Iliocostal distance decreased as the
number of vertebral fractures increase in both women and
men (table 2). Tables 3 and 4 present univariate regres-
sion analysis results in women and men modelled for the
number of vertebral and non-vertebral fractures.
Iliocostal Distance
Women
In women, univariate regression analysis revealed a statis-
tically significant negative association between iliocostal
distance and the number of vertebral and non-vertebral
fractures (Table 3). After adjustments were made for con-
founding variables, multivariable regression analysis
showed that iliocostal distance was negatively associated
with the number of vertebral fractures (-0.18, CI: -0.27, -
0.09; adjusted for bone mineral density at the Ward's tri-
Figure 1
Measurement Technique for Iliocostal Distance. Rep-
resents iliocostal distance. Iliocostal distance was defined as
the number of cm between the costal margin and the pelvic
ridge of a patient, measured in the midaxillary line.BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/22
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Table 1: Baseline characteristics of women and men*
Women n = 508 Men n = 41
Age-years (SD) 61.5 (11.3) 57.8 (12.4)
Height-cm (SD) 160.8 (9.6) 174.8 (18.3)
Weight-kg (SD) 67.8 (14.4) 86.2 (22.0)
Iliocostal distance-cm (SD) 4.2 (1.6) 4.6 (1.5)
Menopausal status-#post/#pre 424/78 NA
Age at menopause-years (SD) 47.3 (6.8) NA
Lumbar spine BMD-g/cm2 (SD) 0.867 (0.165) 0.918 (0.165)
Femoral neck BMD-g/cm2 (SD) 0.664 (0.112) 0.713 (0.124)
Trochanter BMD-g/cm2 (SD) 0.608 (0.107) 0.676 (0.123)
Ward's triangle BMD-g/cm2 (SD) 0.483 (0.133) 0.471 (0.155)
Currently smoking-# 64 6
Family history of fracture-# 122 12
Alcohol-beverages/week (SD) 1.4 (3.0) 5.5 (8.7)
Number of falls – min to max 0–12 0–4
Calcium intake-mg/d (SD) 539.0 (435.9) 553.5 (375.4)
Exercise-minutes/week (SD) 166.7 (165.9) 187.9 (293.0)
Etidronate use-# (%) 50 (9.8) 3 (7.3)
Alendronate use-# (%) 41 (8.1) 7 (17.1)
Fluoride use-# (%) 2 (0.4) 0 (0.0)
Raloxifene use-# (%) 9 (1.8) 0 (0.0)
Hormone replacement use-# (%) 146 (28.7) 0 (0.0)
Corticosteroids use-# (%) 77 (15.2) 8 (19.5)
Calcium supplement use-# (%) 366 (72.0) 16 (39.0)
Vitamin D supplement use-# (%) 173 (34.1) 10 (24.4)
Lung diseasea-# (%) 59 (11.6) 3 (7.3)
Liver diseaseb-# (%) 13 (2.6) 2 (4.9)
Thyroid diseasec-# (%) 69 (13.6) 0 (0.0)
Cancerd-# (%) 14 (2.8) 0 (0.0)
Visual impairment-# (%) 51 (10.0) 2 (4.9)
Osteoporosis-# (%) 187 (36.8) 13 (31.7)
Inflammatory bowel disease-# (%) 15 (3.0) 5 (12.2)
Epilepsy-# (%) 7 (1.4) 2 (4.9)
Coronary disease-# (%) 12 (2.4) 1 (2.4)
Cerebrovascular disease-# (%) 19 (3.7) 1 (2.4)
Rheumatoid arthritis-# (%) 5 (1.0) 0 (0.0)
Diabetes-# (%) 18 (3.5) 0 (0.0)
Kidney failure-# (%) 24 (4.7) 0 (0.0)
* BMD= bone mineral density; SD= standard deviation; # = number of patients; %=percent of patients; NA= not applicable. a Lung disease includes 
asthma, chronic bronchitis and other lung diseases. b Liver disease includes cirrhosis, hepatitis and cholangitis. c Thyroid disease includes hyper, 
hypo, nodule, and other. d Cancer includes breast, ovaries, cervix, uterus and colon.
Table 2: Iliocostal distance and the number of vertebral and non-vertebral fractures in women and men
Women Men
Vertebral Factures
0* 4.53 (1.52) 4.77 (1.54)
1 3.90 (1.73) 4.54 (1.57)
2 3.79 (1.75) 4.00 (2.00)
3 2.91 (1.41) 4.00 (0.00)
4+ 3.75 (2.06) 3.00 (1.41)
* Indicates patients without vertebral or non-vertebral fractures.BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/22
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angle, epilepsy, cerebrovascular disease, inflammatory
bowel disease, etidronate use, and calcium supplement
use) and for the number of non-vertebral fractures (-0.09,
CI: -0.15, -0.03; adjusted for bone mineral density at the
trochanter, cerebrovascular disease, inflammatory bowel
disease, and etidronate use).
Men
In men, univariate regression analysis did not demon-
strate a significant association between iliocostal distance
and the number of vertebral or non-vertebral fractures
(Table 4). The iliocostal distance variable remained non-
significant following multivariable adjustments modelled
for the number of vertebral fractures (-0.12, 95% CI: -
0.41, 0.16; adjusted for age and the number of fall during
Table 3: Univariate parameter coefficient estimates and P-values for the association between risk factors and the number of vertebral 
and non-vertebral fractures in women
No. Vertebral fractures No. Non-Vertebral Fractures
Coefficient P-value Coefficient P-value
Age 0.034 <0.001 0.018 <0.001
Height -0.012 0.083 0.004 0.454
Weight -0.001 0.768 0.002 0.534
Iliocostal distance -0.271 <0.001 -0.115 <0.001
Menopausal status 0.516 0.003 0.305 0.015
Age at menopause 0.001 0.917 -0.006 0.405
Lumbar spine BMD -0.813 0.048 -0.722 0.026
Femoral neck BMD -3.069 <0.001 -1.901 <0.001
Trochanter BMD -3.381 <0.001 -2.415 <0.001
Ward's triangle BMD -2.928 <0.001 -1.951 <0.001
Prevalent vertebral fractures NA 0.310 0.002
Prevalent non-vertebral fractures 0.391 0.003 NA
Currently smoking 0.018 0.759 0.049 0.258
Family history of fracture -0.158 0.305 0.121 0.272
Alcohol-beverages/week -0.013 0.529 -0.012 0.435
No. of falls -0.004 0.935 0.079 0.017
Calcium intake -0.000 0.499 0.000 0.536
Exercise -0.000 0.248 -0.000 0.895
Etidronate use 0.315 0.003 0.188 0.014
Alendronate use 0.250 0.009 0.062 0.366
Fluoride use 0.392 0.541 0.843 0.067
Raloxifene use -0.053 0.807 0.167 0.280
Hormone replacement use -0.069 0.551 -0.001 0.992
Corticosteroids use 0.113 0.308 -0.046 0.564
Calcium supplement use 0.302 0.006 0.107 0.171
Vitamin D supplement use 0.147 0.115 0.094 0.163
Lung diseasea 0.223 0.264 0.334 0.020
Liver diseaseb -0.068 0.866 -0.143 0.621
Thyroid diseasec -0.185 0.318 0.060 0.656
Cancerd 0.327 0.400 0.190 0.495
Visual impairment 0.136 0.526 0.174 0.258
Osteoporosis -0.109 0.409 0.002 0.982
Inflammatory bowel disease -0.634 0.091 0.618 0.022
Epilepsy 1.047 0.054 -0.175 0.656
Coronary disease 0.582 0.164 0.401 0.174
Cerebrovascular disease 1.042 0.002 1.016 <0.001
Rheumatoid arthritis 0.083 0.898 0.403 0.383
Diabetes 0.157 0.648 0.241 0.328
Kidney failure 0.115 0.700 0.200 0.352
* BMD= bone mineral density, NA= not available. a Lung disease includes asthma, chronic bronchitis and other lung diseases. b Liver disease includes 
cirrhosis, hepatitis and cholangitis. c Thyroid disease includes hyper, hypo, nodule, and other. d Cancer includes breast, ovaries, cervix, uterus and 
colon.BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/22
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the past year) and the number of non-vertebral fractures
(0.11, 95% CI: -0.18, 0.41; adjusted for number of falls
during year, visual problems that are not corrected by eye-
glasses or contacts, and height).
Discussion
Osteoporosis is under-diagnosed, under-treated and a
large number of individuals are unaware that they have
this disease. With the emergence of effective treatments it
is essential to detect those patients with a vertebral frac-
ture and those with at higher risk of fracture. At present,
there is no universally accepted policy for identifying pa-
tients with osteoporosis. Clinical risk assessment is an im-
portant step in identifying individuals at high risk for
osteoporosis and fractures. To our knowledge, the rela-
tionships between iliocostal distance and the number of
prevalent vertebral and non-vertebral fractures have not
been previously reported.
Table 4: Univariate parameter coefficient estimates and P-values for the association between risk factors and the number of vertebral 
and non-vertebral fractures in men*
No. Vertebral fractures No. Non-Vertebral Fractures
Coefficient P-value Coefficient P-value
Age 0.035 0.072 -0.005 0.788
Height -0.034 0.010 -0.017 0.164
Weight 0.007 0.523 0.015 0.155
Iliocostal distance -0.259 0.095 -0.037 0.796
Lumbar spine BMD -2.360 0.174 -0.399 0.779
Femoral neck BMD -1.378 0.511 -0.106 0.953
Trochanter BMD -1.728 0.410 -0.822 0.646
Ward's triangle BMD -2.138 0.196 0.275 0.846
Prevalent vertebral fractures NA 0.396 0.361
Prevalent non-vertebral fractures -0.090 0.851 NA
Currently smoking 0.036 0.876 0.161 0.443
Family history of fracture -0.538 0.330 -0.647 0.184
Alcohol-beverages/week -0.002 0.933 0.043 0.079
No. of falls 0.691 0.002 0.561 0.006
Calcium intake-mg/d 0.001 0.028 0.000 0.600
Exercise-min/week -0.000 0.683 -0.001 0.484
Etidronate use 0.259 0.574 -0.180 0.665
Alendronate use 0.589 0.038 0.036 0.891
Fluoride use NA NA
Raloxifene use NA NA
Hormone replacement use NA NA
Corticosteroids use -0.479 0.286 0.000 1.000
Calcium supplement use -0.014 0.972 -0.370 0.279
Vitamin D supplement use 0.010 0.977 0.000 1.000
Lung diseasea -0.921 0.315 0.000 1.000
Liver diseaseb 1.205 0.276 1.051 0.292
Thyroid diseasec NA NA
Cancerd NA NA
Visual impairment -0.257 0.810 1.635 0.082
Osteoporosis 1.003 0.046 0.113 0.809
Inflammatory bowel disease -0.517 0.480 0.000 1.000
Epilepsy -0.897 0.419 -1.051 0.292
Coronary disease -0.875 0.574 0.000 1.000
Cerebrovascular disease 3.225 0.033 3.075 0.024
Rheumatoid arthritis NA NA
Diabetes NA NA
Kidney failure NA NA
* BMD= bone mineral density, NA= not available. a Lung disease includes asthma, chronic bronchitis and other lung diseases. b Liver disease includes 
cirrhosis, hepatitis and cholangitis. c Thyroid disease includes hyper, hypo, nodule, and other. d Cancer includes breast, ovaries, cervix, uterus and 
colon.BMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/22
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Our findings indicated that iliocostal distance is negative-
ly associated with the number of vertebral and non-verte-
bral fractures in women, such that the shorter the distance
the greater number of fractures. Iliocostal distance can be
used to identify individuals with vertebral fractures and
may be an excellent risk factor for future fractures and
should be included in a patient risk profile. This measure-
ment is easy to obtain and assess in a clinical setting, can
be measured for all patients, and has a high predictive val-
ue for prevalent fracture independent of other known risk
factors such as bone mineral density. From our clinical ex-
perience, healthy adults have an iliocostal distance of ap-
proximately 6 cm.
Vertebral fractures are a well-recognized consequence of
postmenopausal bone loss and are the most common os-
teoporotic fractures [9]. It is estimated that less than one
third of all vertebral fractures are clinically diagnosed
[10]. A common explanation is that fractures are frequent-
ly asymptomatic and patients who suffer them are not
prompted to seek medical attention. Furthermore, physi-
cians may not be identifying prevalent fractures among
their patients. The early identification of a vertebral frac-
ture is essential. It has been shown that women who de-
velop a vertebral fracture are at increased risk for an
additional vertebral fracture [11] and that 20% of women
will experience a subsequent fracture within the one year
following the first vertebral fracture [12]. Moreover, there
is growing evidence that all vertebral fractures are associ-
ated with adverse health consequences. Nevitt et al. [13]
have found that back pain, functional limitation and dis-
ability days are associated with fractures. Among this large
cohort of women 65 years of age and older, patients who
sustained fractures were 2 to 3 fold more likely to experi-
ence more back pain and disability when performing
back-dependent activities of daily living as compared with
the unaffected comparison group. Likewise, fracture pa-
tients were at higher risk of experiencing limited activity
days and days confined to bed. Kado et al. [14] observed
that women who developed new fractures over a duration
of 8 years had a 23% increased risk of mortality. This
study also found a dose response effect such that mortality
increased with the number of fractures. Accordingly, it is
important that physicians recognize patients at risk for
vertebral fracture or patients that have sustained fractures.
It is not surprising that iliocostal distance measurements
in women were also associated with non-vertebral frac-
tures. Vertebral fractures are early indicators of other oste-
oporotic fractures [15–17]. For instance, it has been
shown that women who have a prevalent vertebral frac-
ture have an increased relative risk (RR) of a subsequent
fracture at the wrist (RR = 1.4), hip (RR = 2.3), and all
non-spinal sites (RR = 1.8) as compared with unaffected
women [11].
Our results showed that iliocostal distance values were as-
sociated with fractures in women but not in men. The ap-
parent differences between women and men are difficult
to explain; however, others have found gender differences
in risk factors for increased bone loss in an elderly popu-
lation [18]. Nonetheless, due to the low number of men
(n = 41) recruited in this study (and the low statistical
power) caution should be taken in the interpretation of
the results. Further research will need to be conducted in
men to confirm or dispute our findings.
Several features of the study are unique, and thus reinforce
our conclusions. For example, all participants were "real
world" patients who were seen for osteoporosis in a terti-
ary care setting and thus represent a homogeneous group.
Other strengths included the large sample size of women,
the careful delineation of potential confounding variables
studied, and the wealth of data available about the study
cohort. Nonetheless, our study is not without limitations.
The study was cross-sectional in design and partially de-
pended on information obtained by recall. Although ad-
justments were made for several variables, it remains
possible that other, unknown determinants of fracture
confound the observed associations. Due to the lack of da-
ta, no distinction was made between lumbar and thoracic
fractures. Moreover, only one investigator assessed ilio-
costal distance using fingerbreadth as the measurement
device, as such future validation of this useful clinical tool
in terms of inter-rater reliability is recommended. Not all
spinal fractures were confirmed by x-ray. X-rays were per-
formed only in patients with back pain. Therefore, sub-
clinical vertebral fractures may have developed. As a
consequence, the actual association between iliocostal
distance and the number of vertebral fractures may have
been underestimated. The relationship between iliocostal
distance and vertebral fractures should be tested in those
patients with subclinical fractures.
Conclusions
At present, only a small number of patients at high risk for
fracture are currently recognized. Indeed, vertebral frac-
tures often do not produce symptoms, so that many indi-
viduals with fractures will not seek medical attention for
the problem. However, all vertebral fractures, whether
symptomatic or radiographically identified, are associated
with increased mortality and morbidity. The challenge for
primary care physicians is to prevent, diagnose, and treat
osteoporosis as early as possible. Thus, identification is
the first step in osteoporosis management. The examina-
tion of iliocostal distance may be an excellent clinical op-
portunity to identify osteoporotic individuals for referral
for diagnosis, preventive counseling and management.
The identification of high-risk patients is important to ef-
fectively use the growing number of available osteoporo-
sis therapies. Longitudinal studies will need to beBMC Musculoskeletal Disorders 2002, 3 http://www.biomedcentral.com/1471-2474/3/22
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conducted to determine the association between changes
in iliocostal distance measurements and fractures.
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